Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
10.44
+0.29 (2.86%)
Nov 3, 2026, 9:58 AM EST - Market open
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $653.35 million as of November 3, 2026. It is the 12,769th most valuable company in the world and the 2,562nd biggest in the United States. Its market cap has increased by 71.24% in one year.
Market Cap
653.35M
Enterprise Value
448.62M
1-Year Change
71.24%
Global Rank
Country Rank
#2,562 United States
Category
ChartMarket Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $653.35M, a decrease of -70.38%. That is a compound annual growth rate of -19.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 653.35M | 22.28% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ArriVent BioPharma | 658.26M |
| Solid Biosciences | 643.35M |
| Helus Pharma | 642.93M |
| Apnimed | 641.11M |
| Lexicon Pharmaceuticals | 640.74M |
| 4D Molecular Therapeutics | 628.13M |
| Aura Biosciences | 625.34M |
| Nuvectis Pharma | 624.91M |